Skip to main content

Find Clinical Trials

Home
Conditions
Herpesviridae Infections

Clinical trial condition

Herpesviridae Infections

Explore clinical trials studying Herpesviridae Infections. Study availability and eligibility vary by location and protocol.

1,824 public trials 252 recruiting studies

Refine in advanced search Browse all conditions

Herpesviridae Infections trial results

Completed

A Study of Valcyte (Valganciclovir) Syrup Formulation in Pediatric Solid Organ Transplant Recipients

NCT00090766

Conditions: Cytomegalovirus Infections, DNA Virus Infections, Herpesviridae Infections, +2 more
Locations: Los Angeles, California, United States

Indianapolis, Indiana, United States

Ann Arbor, Michigan, United States

St Louis, Missouri, United States

View all 17 locations

View Trial Details

Completed

Valacyclovir Augmentation for Cognitive and Functional Remediation in Schizophrenia

NCT01794897

Conditions: DNA Virus Infections, Herpes Simplex, Herpesviridae Infections, +11 more
Locations: Dr. Ram Manohar Lohia Hospital Delhi, India

View Trial Details

Completed

Immunogenicity, Safety of Measles-mumps-rubella-varicella Vaccine (MeMuRu-OKA) Compared to Priorix™ Given With Varilrix™

NCT00353288

Conditions: Chickenpox, DNA Virus Infections, Herpesviridae Infections, +19 more
Locations: GSK Investigational Site Ancenis, France

GSK Investigational Site Boulogne, France

GSK Investigational Site Dax, France

GSK Investigational Site Draguignan, France

View all 39 locations

View Trial Details

Completed

Immunogenicity, Safety of Measles-mumps-rubella-varicella Vaccine (MeMuRu-OKA) Compared to Priorix™ Given With Varilrix™

NCT00352898

Conditions: Chickenpox, DNA Virus Infections, Herpesviridae Infections, +19 more
Locations: GSK Investigational Site Edmonton, Alberta, Canada

GSK Investigational Site Vancouver, British Columbia, Canada

GSK Investigational Site Halifax, Nova Scotia, Canada

GSK Investigational Site Enna, Sicily, Italy

View Trial Details

Completed

Identifying Risk Factors for Eczema Herpeticum in Individuals With Atopic Dermatitis

NCT00438022

Conditions: Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, DNA Virus Infections, +18 more
Locations: University of Bonn, Germany Bonn, Germany

View Trial Details

Completed

Evaluation of Tc 99m Tilmanocept Localization in Primary Cutaneous Kaposi's Sarcoma and Lymphatic Drainage by SPECT/CT

NCT02201420

Conditions: DNA Virus Infections, Herpesviridae Infections, Infections, +8 more
Locations: San Francisco General Hospital San Francisco, California, United States

View Trial Details

Completed

Monoclonal Antibody Therapy in Treating Patients With Lymphoma or Colon Cancer That Has Not Responded to Vaccine Therapy

NCT00047164

Conditions: Burkitt Lymphoma, Chronic Disease, DNA Virus Infections, +33 more
Locations: Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office Bethesda, Maryland, United States

View Trial Details

Completed

Immunogenicity and Safety of a Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox Diseases

NCT00127010

Conditions: Chickenpox, DNA Virus Infections, Herpesviridae Infections, +19 more
Locations: GSK Investigational Site Brussels, Belgium

GSK Investigational Site Leuven, Belgium

GSK Investigational Site Bad Saulgau, Baden-Wurttemberg, Germany

GSK Investigational Site Bönnigheim, Baden-Wurttemberg, Germany

View all 48 locations

View Trial Details

Completed

Immunogenicity and Safety of a Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox Diseases

NCT00127023

Conditions: Chickenpox, DNA Virus Infections, Herpesviridae Infections, +19 more
Locations: GSK Investigational Site Bad Saulgau, Baden-Wurttemberg, Germany

GSK Investigational Site Bönnigheim, Baden-Wurttemberg, Germany

GSK Investigational Site Bretten, Baden-Wurttemberg, Germany

GSK Investigational Site Ehingen, Baden-Wurttemberg, Germany

View all 85 locations

View Trial Details

Completed

Immunogenicity and Safety of Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox Diseases

NCT00126997

Conditions: Chickenpox, DNA Virus Infections, Herpesviridae Infections, +19 more
Locations: GSK Investigational Site Espoo, Finland

GSK Investigational Site Lahti, Finland

GSK Investigational Site Oulu, Finland

GSK Investigational Site Pori, Finland

View all 54 locations

View Trial Details